Sep 29 2026 11:04 PM EST

Babcock & Wilcox Shares Slip Amid Warrant Volatility and Refinancing Concerns

The stock closed at $5.81 on September 29, 2026, down 21.7% over the prior five‑day period. The decline follows a broader slide of 22.9% for the month and an 8.4% drop year‑to‑date, prompting investors to reassess the company’s near‑term earnings profile.

In the first quarter of 2026, Babcock & Wilcox Enterprises (NYSE: BW) reported revenue of $214.4 million, a 44% YoY increase, driven by a $60 million rise in large‑project volume. Adjusted EBITDA surged 296% to $16.1 million. However, GAAP net loss widened to $79.6 million, primarily because of $81.8 million of non‑cash warrant and stock‑related charges tied to the rising share price.

Warrant Valuation Drives GAAP Losses

The $81.8 million expense reflects a fair‑value adjustment to customer warrants, a recurring non‑cash item that has created volatility between reported and adjusted earnings. In Q2 2026 the company recorded a favorable $5.9 million change in warrant fair value, yet the prior year’s loss of $64.4 million remains a reference point for analysts monitoring earnings consistency.

Liquidity Improves but Refinancing Risk Persists

Cash and restricted cash stood at $194.8 million as of March 31, 2026, with secured debt of $237.2 million, leaving net debt of $42.4 million. The firm repaid $15 million of its December 2026 bonds in Q1 and expects to retire the remainder before year‑end, reducing refinancing exposure. Nonetheless, analysts note that the company must still address $84.8 million of 6.5% senior notes due 2026, a source of ongoing credit‑risk scrutiny.

Recent Contract Wins Bolster Backlog

The Q2 2026 earnings release showed revenue of $319.7 million, up 130% YoY, driven by the Base Electron AI data‑center project (>$100 million) and a new Siemens Energy agreement for 1 GW of steam turbines. The company’s uncontracted pipeline grew 17% to exceed $14.0 billion, and a $130 million air‑quality control award was announced in September. Management reaffirmed its FY 2026 adjusted EBITDA target of $80‑$100 million, later raised to $80‑$105 million.

Analyst Sentiment Mixed

Consensus ratings sit at “Hold” with an average target price of $15.40. The coverage mix includes one upgrade (Wall Street Zen to Hold) and one downgrade (Weiss Ratings to Sell). AAII assigns a Value Grade of **F** (Ultra Expensive) but a Momentum Score of 95, reflecting strong short‑term price strength despite perceived overvaluation.

Risks and Uncertainties

Key risks include continued volatility from warrant fair‑value adjustments, the need to refinance or retire the remaining senior notes, and a backlog that fell from $495 million at year‑end 2025 to $424 million. Macro headwinds—persistent inflation, interest‑rate uncertainty, foreign‑exchange swings and supply‑chain disruptions—could pressure margins. Additionally, ongoing securities‑class‑action litigation adds legal uncertainty.